Plunkett Research Online: AIM ImmunoTech Inc

AIM IMMUNOTECH INC (AIM) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alfero.....


AIM IMMUNOTECH INC

Ticker: AIM
Exchange: NYS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 352-448-7797
Fax:
Address: 2117 SW Highway 484
Ocala, FL 34473 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Thomas Equels CEO/Director/President/Vice Chairman of the Board
Adam Pascale CFO/Chief Accounting Officer
See More
AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alfero.....See More See More

$USD, In whole numbers 2020 2019 2018 2017 2016 2015 2014
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture